Nyxoah (NYXH) Depreciation & Amortization (CF) (2021 - 2022)

Nyxoah (NYXH) recorded quarterly Depreciation & Amortization (CF) of $292811.0 in Q4 2022, down 1.89% quarter-over-quarter from $298449.2 in Q3 2022, and down 32.11% on a YoY basis from $431277.0 in Q4 2021.

Nyxoah (NYXH) Depreciation & Amortization (CF) (2021 - 2022) Analysis & Trends

Nyxoah's Depreciation & Amortization (CF) history runs 2 years deep, the most recent figure standing at $292811.0 for Q4 2022.

  • In Q4 2022, Depreciation & Amortization (CF) fell 32.11% year-over-year to $292811.0; the TTM figure through Sep 2023 stood at $292811.0 (down 77.75% YoY), while the FY2025 annual figure was $2.6 million, up 40.14% from the prior year.
  • Depreciation & Amortization (CF) was $292811.0 for Q4 2022 at Nyxoah, down from $298449.2 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $431277.0 in Q4 2021 to a low of $197822.7 in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn 178.90 Mn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn 563.00 Mn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn 254.00 Mn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn 58.98 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn 44.60 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn 135.00 Mn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn 95.40 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn 56.55 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn 237.00 Mn
10 Nyxoah 0.69 0.69 4.26 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2022 292,810.99
Dec 31, 2022 292,810.99
Sep 30, 2022 298,449.20
Sep 30, 2022 298,449.20
Jun 30, 2022 299,842.93
Jun 30, 2022 299,842.93
Mar 31, 2022 286,196.12
Mar 31, 2022 286,196.12
Dec 31, 2021 431,277.05
Dec 31, 2021 431,277.05
Sep 30, 2021 213,451.01
Sep 30, 2021 213,451.01
Jun 30, 2021 256,509.82
Jun 30, 2021 256,509.82
Mar 31, 2021 197,822.72
Mar 31, 2021 197,822.72